Calprotectin has been established as a key biomarker in differential diagnosis and follow-up of patients with inflammatory bowel disease, and is also used as a screening tool prior to invasive procedures such as endoscopy.
Calpro produced the first commercial kits available for measuring Calprotectin and thus established cut-offs and standards all subsequent tests would follow.
Calpro is a world-leading provider of Calprotectin tests. Our aim is to provide solutions that are effective and user-friendly for the user, without compromising on the quality of the products.
Calpro provides various products covering three ranges: Laboratory tests based on ELISA technology, Extraction devices for laboratory use & Rapid test for point-of-care or self test/home monitoring
Product Documentation for the Calprotectin solutions is available in up to 18 languages. Click the button to access the documents of your choice.
Calprotectin is a rather small protein making up around 60% of the cytosol of Neutrophiles. It is released to the surrounding environment when the immune system is activated as a response to microbial or fungal infections and is used in the diagnosis of inflammatory bowel disease (IBD) to differentiate it from the functional irritable bowel syndrome (IBS). It is also routinely used in the follow-up of patients with IBD to predict relapse or determine response to treatment.
Calprotectin is a non-specific biomarker, such as the more commonly used C-Reactive Protein (CRP); however, the stability of the protein, robustness, and local release without need for synthesis makes it a preferred biomarker for IBD. As such, the protein can be and is used in the diagnosis and follow-up of a variety of diseases.
ONLINE PRESENTATION/WEBINAR LIBRARY
E-Health has in recent years emerged as a great tool for patients to remain prolonged periods in remission. E-Health is different from phone or online consultations, in that the latter will only provide the treating physician with the patients' subjective observations. For optimal distant monitoring, objective parameters are also required. When done correctly, e-Health has great benefits for the patient, the physicians, the hospital, and the society as a whole, and can drastically reduce the use of heavy medication, emergency admissions, surgeries, and other expensive treatments.
Calpro is a Norwegian based bio-tech company dedicated to research on and developement of Calprotectin based diagnostic tests. Focussing on one specific biomarker, the company has a knowledge base unlike any other; Those who discovered and characterized Calprotectin later went on to create Calpro, and the company is one of the major suppliers of diagnostic tools based around the protein.
CalproSmart self-test, CAL201, CAL202, CAL230, CAL240, CAL250
Self-test for distant management